Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Sirnaomics Ltd. ( (HK:2257) ).
Sirnaomics Ltd. plans to amend its existing memorandum and articles of association to align with recent changes to Hong Kong Listing Rules on hybrid general meetings and electronic voting, along with other housekeeping updates. The company will seek shareholder approval for the adoption of a sixth amended and restated memorandum and articles at its upcoming annual general meeting, with further details to be provided in a forthcoming circular, signaling a move toward more flexible and technology-enabled corporate governance.
If approved at the AGM, the governance changes are expected to enhance Sirnaomics’ ability to conduct meetings in hybrid formats and support electronic participation and voting by shareholders. This modernization of its constitutional documents may improve shareholder engagement, operational efficiency, and regulatory compliance, potentially strengthening the company’s standing in the Hong Kong capital market.
The most recent analyst rating on (HK:2257) stock is a Hold with a HK$8.00 price target. To see the full list of analyst forecasts on Sirnaomics Ltd. stock, see the HK:2257 Stock Forecast page.
More about Sirnaomics Ltd.
Sirnaomics Ltd. is a Cayman Islands-incorporated company listed on the Hong Kong Stock Exchange under stock code 2257. The company operates within the biopharmaceutical sector, focusing on the development and commercialization of RNA-based therapeutics and related innovative medical treatments for global markets.
Average Trading Volume: 243,455
Technical Sentiment Signal: Sell
Current Market Cap: HK$806.5M
Find detailed analytics on 2257 stock on TipRanks’ Stock Analysis page.